Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLP-1 versus metformin for polycystic ovary syndrome
ChiCTR-TRC-12002307Phase 3Completed
- Sponsor
- The Second Hospital of Jilin University
- Start
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of GLP-1 analog (Rani Therapeutics) and metformin in polycystic ovary syndrome (PCOS) (2 arms), sponsored by The Second Hospital of Jilin University. Primary endpoints: BMI, C-peptide and 9 more. Started Mar 2011; status: completed.
02
Drugs
GLP-1 analog (Rani Therapeutics)metformin
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on ChiCTR-TRC-12002307.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12002307.